Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACT: Treg Adoptive Cell Transfer in Kidney Transplant
NCT02145325Phase 1Completed
- Sponsor
- Northwestern University
- Start
- Apr 2014
- Primary completion
- Jun 2016
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of expanded regulatory T cells in kidney transplant rejection, sponsored by Northwestern University. Primary endpoint: Safety Profile Assessment of TRACT at 5 years. Started Apr 2014; status: completed.
02
Drugs
expanded regulatory T cells
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02145325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145325.